Pharmaceutical group ยท Switzerland
Serono
A group of 6 companies with 48 medicines in 6 countries.
Group structure
6 companies in 6 countries
Loading your pageโฆ
Pharmaceutical group ยท Switzerland
A group of 6 companies with 48 medicines in 6 countries.
6 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 48
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| FERTINEX150 iu/amp | 75 iu/amp ยท Injectable | Urofollitropin | United States | Not marketed | 1986 |
| METRODIN150 iu/amp | 75 iu/amp ยท Injectable | Urofollitropin | United States | Not marketed | 1986 |
| NOVANTRONE20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2MG BASE/ML | 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product wa ยท Injectable | Mitoxantrone | United States | Not marketed | 1987 |
| PERGONAL150 iu/amp; 150 iu/amp | 75 iu/amp; 75 iu/amp ยท Injectable | Menotropins (fsh, Lh) | United States | Not marketed | 1975 |
| REBIF1a 22ug/0.5ml | 1a 44ug/0.5ml ยท Syringe | Interferon beta-1a | United States | Marketed | 2002 |
| GONAL-F 150 IU AMPOULE | Follitropin alfa | Saudi Arabia | Authorised | |
| GONAL-F 75 IU AMPOULE | Follitropin alfa | Saudi Arabia | Authorised | |
| LUVERIS 75 I.U. POWDER FOR SOLU. FOR INJ | Lutropin alfa | Saudi Arabia | Authorised | |
| METRODIN HP 75 IU-AMPOULE | Urofollitropin | Saudi Arabia | Authorised | |
| OVITRELLE 250MCG-0.5ML PRE-FILLED SYRING | Choriogonadotropin alfa | Saudi Arabia | Authorised | |
| OVITRELLE 250MCG POWDER & SOLVENT FOR INJ | Choriogonadotropin alfa | Saudi Arabia | Authorised | |
| PERGONAL 75 IU- AMPOUL | Human menopausal gonadotrophin (fsh, Lh) | Saudi Arabia | Authorised | |
| PROFASI AMP 1000 I.U.+SOLVENT | Gonadotrophin chorionic human | Saudi Arabia | Authorised | |
| PROFASI AMP 500 I.U+SOLVENT | Gonadotrophin chorionic human | Saudi Arabia | Authorised | |
| PROFASI AMP 5000 I.U.+SOLVENT | Gonadotrophin chorionic human | Saudi Arabia | Authorised | |
| REBIF 22 MCG PRE-FILLED SYRINGE | Interferon beta-1a | Saudi Arabia | Authorised | |
| REBIF 44 MCG PRE-FILLED SYRINGE | Interferon beta-1a | Saudi Arabia | Authorised | |
| SAIZEN 1.33MG VIAL | Somatropin | Saudi Arabia | Authorised | |
| SAIZEN 8MG CLICK EASY | Somatropin | Saudi Arabia | Authorised | |
| SEROCRYPTIN 2.5MG TAB | Bromocriptine | Saudi Arabia | Authorised | |
| STILAMIN 250MCG AMP+SOLVENT | Somatostatin | Saudi Arabia | Authorised | |
| STILAMIN 3MG AMP+SOLVENT | Somatostatin | Saudi Arabia | Authorised | |
| ACETATO DE LEUPROLIDE | Brazil | Cancelled | 1999 | |
| ACICLOVIR | Brazil | Cancelled | 1999 | |
| CETROTIDE | Cetrorelix | Brazil | Cancelled | 2001 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 23 | 0 | 23 | CompaniesAll medicines |
| Saudi Arabia | 17 | 17 | 0 | CompaniesAll medicines |
| United States | 5 | 5 | 0 | CompaniesAll medicines |
| Canada | 1 | 0 | 1 | CompaniesAll medicines |
| European Union (EMA) | 1 | 0 | 1 | CompaniesAll medicines |
| Romania | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Italy
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: ยฉ OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.